Form 4 Filing: Krishnan Mahesh Sells $829K of $HALO

INSIDER SALE

⚡ MATERIALITY: 5/10

corporate issuer

HALOZYME THERAPEUTICS, INC.

Ticker: $HALO

Transaction Value

$829K

Price/Share: $56.73

transaction date

2026-06-29

Shares: 14,608

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Krishnan Mahesh, holds the title of Director at HALOZYME THERAPEUTICS, INC..

On 2026-06-29, the insider transacted 14,608 shares.The shares were transacted at a weighted average price of $56.73 per share, resulting in a total market-relevant value of $829K.

Executive Summary Summary

Krishnan Mahesh (Director) sold $829K of $HALO

Post-Transaction Position: 14,462 shares

SEC Accession No: 0001159036-26-000082 (CIK: 1866746)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$HALO Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$HALO News Coverage